Overton Sidesteps Policy Questions as Novo Nordisk Bets $1.3 Billion on Long-Acting Injections

By Ed Silverman · STAT News · 2026-09-25

Overton Sidesteps Policy Questions as Novo Nordisk Bets $1.3 Billion on Long-Acting Injections

According to STAT News, FDA commissioner nominee Heidi Overton maintained a neutral stance during her Senate confirmation hearing, avoiding specific commitments on controversial regulatory topics. Meanwhile, Novo Nordisk is investing heavily in Nanexa’s PharmaShell delivery syste

According to STAT News, FDA commissioner nominee Heidi Overton maintained a neutral stance during her Senate confirmation hearing, avoiding specific commitments on controversial regulatory topics. Meanwhile, Novo Nordisk is investing heavily in Nanexa’s PharmaShell delivery syste